Navigation Menu+
The Pursuit of 100
Read more

The Most Excellent, Yet Elusive Number In grammar school, we are encouraged to strive for perfection. Our papers were often graded with A, B, or C marks and depending on your performance, you may also earn a “+” or “-” symbol with these grades. The basis of these grades are often measured against a 100-point scale with a A+ being the prestigious mark of...

Read more
Chocolate, Just For Fun.
Read more

The other night, I caught my beautiful wife grabbing some chocolate out of the refrigerator. I asked if she was feeling okay and she said, yes, “I just wanted some chocolate.” Her nonchalant and genuine response warmed my heart and put a big smile on my face. As a spouse of someone with Type 1 Diabetes, I’m used to my loved one politely passing...

Read more
Dexcom’s New Continuous Glucose Monitor: G4 Plantinum System w/ Share
Read more

At the start of this year, the FDA approved Dexcom’s latest model of its continuous glucose monitor, the Dexcom G4® Plantinum System with Share™.  A continuous glucose monitor (CGM) is a device that uses a glucose sensor or tiny electrode to measure the body’s glucose levels. A CGM takes multiple readings of the body’s glucose reading through the hour, which helps type 1 diabetes patients regulate their glucose levels...

Read more
No More Shots?
Read more

Finger Pricking and insulin shots are daily routines that Type 1 Diabetics experience. However, what if there was only finger pricking and no shots?   Recently, Afrezza – an inhaled insulin – has breathed new life into the daily habits of Type 1 Diabetics. Afrezza, an inhaled insulin, is meant to replace bolus or mealtime insulin. Although it not does not replace basal or long-lasting insulin, Afrezza works as a...

Read more
Follow The Money…
Read more

As the saying from All The President’s Men holds, if you want to get to the bottom of something, “follow the money.” In the latest quarterly report from Medtronic, I noticed this largest multinational company had recently funded Glooko, a type 1 diabetes monitoring software. Along with Medtronic, IBM Watson Health, an extension of IBM, participated in the $16.5 million Series B funding. As I was curious to see what Medtronic...

Read more